𧬠SS-31 (Elamipretide) | Mitochondrial Bioenergetic Peptide
SS-31, also known as Elamipretide, is a mitochondria-targeting tetrapeptide designed to support mitochondrial structure, optimize energy output, and reduce oxidative stress. Research models and preclinical studies highlight its broad potential in addressing cellular dysfunction driven by mitochondrial decline.
SS-31 exhibits its bioactivity by localizing to the inner mitochondrial membrane, where it binds to cardiolipin ā a phospholipid critical for mitochondrial stability and function. By stabilizing cardiolipin, SS-31 helps preserve the shape and integrity of mitochondrial cristae, optimizing the organelleās ability to produce energy.
š§² Key Actions in Research Models:
Mitochondria are central to cellular energy and resilience. Dysfunction at this level can trigger cascading issues across organ systems. SS-31 has demonstrated potential in restoring mitochondrial structure and bioenergetics:
In models of inflammation-induced cognitive decline, SS-31 improved mitochondrial function and cognitive performance, showing potential in research focused on age-related brain changes and neuroinflammation.
SS-31 has shown renoprotective effects in kidney-related studies by:
In cardiac models, SS-31 has improved mitochondrial efficiency, reduced ROS, and enhanced overall cardiac performance. Notably, in Barth Syndrome, it has:
SS-31 has shown promise in:
SS-31 aids in restoring autophagic flux, protecting against muscle ischemia in aging models. It:
SS-31 has demonstrated the ability to:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use, and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.
Stay inspired, informed and connected.